
	Where results make sense

Topic: Pharmacia

Related Topics

Lists of companies

Shire Pharmaceuticals

SSAB

Eli Lilly and Company

Pfizer

Benzphetamine

AstraZeneca plc

Akzo Nobel

Vattenfall

List of Swedish companies

List of pharmaceutical companies

Abbott Laboratories

Luxor AB

Bayer

GlaxoSmithKline

In the News (Tue 14 Feb 12)

EXECUTIVE POWER

Iran

ANALYSIS

Pakistan

Family compact

	Pharmacia - Wikipedia, the free encyclopedia
		Pharmacia, founded in 1911, was originally a government-owned Swedish pharmaceutical company.
		The merged company "Pharmacia and Upjohn" was there after bought by the American bioindustry and medical company Monsanto.
		In January 16, 2006, Pharmacia Diagnostics announced that its name was changed to Phadia, which has ended the use of the Pharmacia trademark.
	en.wikipedia.org /wiki/Pharmacia (187 words)

	Monsanto, Pharmacia & Upjohn agree to merge
		Monsanto and Pharmacia said they expected to achieve annual cost savings of more than $600 million, some of which would be reinvested in the company.
		Pharmacia Chief Executive Fred Hassan, credited with improving profits at the drug company since he took over as chief executive in 1997, would be president and CEO of the combined company.
		Monsanto and Pharmacia said they planned to offer up to 19.9 percent of the agribusiness unit in an initial public offering, and would operate it as a separate legal entity with its own stock and board of directors.
	www.biotech-info.net /monsanto_pharmacia.html (838 words)

	Pharmacia (Site not responding. Last check: 2007-10-13)
		Pharmacia was originally a government owned Swedish pharmaceutical company.
		The merged company Pharmacia & Upjohn was there after bought by the American bioindustry and medical company Monsanto.
		The bid was accepted by the stockholders in December 2002 and is awaiting approval from the European Union competition authorities.
	www.ebroadcast.com.au /lookup/encyclopedia/ph/Pharmacia.html (110 words)

	2 for Tuesday: Buying the Pharmacia
		Pharmacia is also on the verge of becoming purely a drug company again, as it prepares to spin off the controversial agricultural business it inherited after its merger with Monsanto (MON:NYSE - news - commentary - research - analysis) in early 2000.
		Pharmacia will file for FDA approval for the use of eplerenone for hypertension by the first quarter of next year and then for congestive heart failure in 2003.
		Pharmacia's strategic outlook after it spins off Monsanto also intrigues me. Lately, the pharmaceutical industry has embraced the notion that bigger is better; the Pfizer (PFE:NYSE - news - commentary - research - analysis)-Warner-Lambert deal is a case in point.
	www.thestreet.com /_cnet/comment/2tuesday/10004812.html (955 words)

	OTERO-CARRASQUILLO v. PHARMACIA (Site not responding. Last check: 2007-10-13)
		Because Pharmacia interpreted the relocation of the fermentation process from Arecibo to Kalamazoo as a "transfer to an affiliated business," and Otero had been offered what it considered a "comparable position," the Plan administrator determined that Otero was not eligible to receive benefits.
		Pharmacia had determined that, because Otero's research associate position had been eliminated due to a transfer of the job to an affiliated business, and because Otero was offered a comparable position as a microbiologist, he was not eligible to receive separation benefits.
		Additionally, to determine whether Pharmacia's promises of comparable employment were fraudulent, the court would have to consult the Plan to determine whether the offered microbiologist position was "comparable" to his prior job as a research associate.
	fsnews.findlaw.com /cases/1st/052373.html (2354 words)

	Realization - Critical Chain - Execution Management - Project Portfolio Management
		Pharmacia is a global drug company with 2001 revenue of over $18 billion, and 59,000 employees in more than 60 countries.
		Concerto is currently used to manage Pharmacia's internal clinical supply preparation at all its facilities as well as research and development work in its biopharmaceutical division.
		Pharmacia management liked the fact that the solution attacked the problem at its roots (rather than merely addressing the symptoms), and was simple.
	www.realization.com /casestudies_pharmacia.htm (511 words)

	Pharmacia Diagnostics
		Pharmacia Diagnostics AB develops, manufactures and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases.
		Pharmacia Diagnostics has been the world leader in its field for over 25 years, and now supplies seven out of 10 of the world's allergy tests.
		Pharmacia Diagnostics is committed to improving the quality of management for patients with allergic or autoimmune conditions by providing high-quality products and services to laboratories, as well as primary- and secondary-care health professionals.
	www.sovereign-publications.com /pharmaciadiagnostics.htm (562 words)

	Pharmacia Initiates U.S. Recall of DELTASONE Tablets (Site not responding. Last check: 2007-10-13)
		Peapack, N.J. - June 18, 2001 -- Pharmacia Corporation announced today that, in cooperation with the U.S. Food and Drug Administration, it is conducting a recall in the United States of its 500 count bottles of DELTASONE Tablets (prednisone tablets, USP), 10 mg, Lot number 29DRB.
		Pharmacia Corporation (NYSE:PHA) is a top-tier global pharmaceutical company with a leading agricultural subsidiary.
		Pharmacia's 59,000 people work together with many diverse stakeholders to bring these benefits to people around the world, and to create new health solutions for the future.
	www.fda.gov /oc/po/firmrecalls/pharmacia6_01.html (418 words)

	Pharmacia/Pfizer: Celebrex Safety Profile Well-Established (Site not responding. Last check: 2007-10-13)
		Pharmacia and Pfizer emphasized that their commitment to patient safety is paramount.
		Pharmacia and Pfizer believe the conclusions drawn by the analysis in the JAMA article were flawed and unsound.
		Pharmacia Corporation is a top-tier global pharmaceutical company with a leading agricultural subsidiary.
	www.pslgroup.com /dg/204792.htm (715 words)

	Pharmacia seen spinning off Monsanto (Site not responding. Last check: 2007-10-13)
		Pharmacia, which declined to comment on its plans for Monsanto, has nonetheless made no bones about its lack of interest in the agricultural business.
		Pharmacia's shares are currently trading at about $40.00, of which about $5.00 is accounted for by the agricultural business, analysts said.
		Analysts said it would be bad for Pharmacia if shareholders didn't sell their Monsanto stock, as it is that part of the business that is hurting Pharmacia.
	www.biotech-info.net /Pharmacia_sells_Monsanto.html (417 words)

	Pharmacia : advertising and marketing profile at Adbrands.net
		Pharmacia is in the process of being merged into drug giant Pfizer.
		The key factor in the deal is blockbuster arthritis drug Celebrex, originally developed by Pharmacia, but marketed by Pfizer, who are keen to take full control of the product, as well as the smaller company's pipeline of other new pharmaceuticals.
		Pharmacia Corporation is itself the result of a series of past mergers, notably the combination in 2000 of the business formerly known as Pharmacia and Upjohn with US crop protection giant Monsanto and its pharmaceutical arm, Searle.
	www.mind-advertising.com /us/pharmacia_us.htm (243 words)

	Pharmacia Diagnostics Terms of use
		Pharmacia will use reasonable efforts to include accurate, complete and up-to-date information on this web site, but Pharmacia makes no warranties or representations as to its accuracy, completeness or frequency that it is updated.
		Pharmacia specifically disclaims all warranties, express or implied, including without limitation, the warranties or merchantability, fitness for a particular purpose, and non-infringement with respect to this web site and information, graphics and materials contained herein.
		Pharmacia does not have responsibility for, or control of, the contents, availability, operation or performance of other web sites to which this web site may be linked or from which this web site may be accessed.
	www.allergietest.nl /misc/terms.htm (2098 words)

	Pharmacia halts cancer drug trials - Feb. 8, 2002
		NEW YORK (CNN/Money) - Pharmacia Corp. said Friday it is halting clinical trials of a colorectal cancer drug after determining that it would not achieve the hoped for clinical benefits.
		Pharmacia's move comes as cancer drug testing has faced increased scrutiny in the wake of a rejected U.S. marketing application from ImClone Systems Inc.
		Pharmacia's trial tested patients on chemotherapy and the new drug with patients only on chemotherapy.
	money.cnn.com /2002/02/08/companies/pharmacia (272 words)

	Pharmacia
		Pfizer to acquire Pharmacia corporation for $60 billion in stock, strategically positioning company for long-term leadership in rapidly changing pharmaceutical industry.
		On July 15 2002, Pfizer Inc and Pharmacia Corporation jointly announced that they have signed a definitive agreement, providing for Pfizer to acquire Pharmacia in a stock-for-stock transaction valued at $60 billion.
		Pharmacia also announced that its Board of Directors intends to proceed with its previously announced spin-off of its remaining 84% ownership of Monsanto to its current shareholders.
	www.pfizer.co.uk /template4.asp?pageid=136 (511 words)

	Problem-Solving Skills and Assistive Technology Equal Long-term Career Success for Pharmacia Systems Engineer - ...
		Pharmacia is a company that takes its diversity seriously.
		Pharmacia Corporation is a leading global pharmaceutical enterprise with a robust product portfolio, wide geographic reach and balance, and a $2 billion research engine to drive new product flow.
		On July 15, 2002, Pharmacia and Pfizer Inc. (NYSE: PFE) announced the signing of a definitive agreement providing for Pfizer to acquire Pharmacia in a stock-for-stock transaction.
	www.microsoft.com /enable/casestudy/pharmacia.aspx?v=p (1068 words)

	Pfizer Inc. - Analysis (Site not responding. Last check: 2007-10-13)
		Pfizer and Pharmacia are required to provide transitional services to the darifenacin buyer relating to regulatory approvals and manufacturing of darifenacin.
		Pfizer and Pharmacia are also required to provide incentives to these individuals to accept employment with the darifenacin acquirer.
		Pfizer and Pharmacia are required to provide Nastech and Neurocrine the opportunity to enter into employment contracts with individuals who have experience relating to IN APO or PNU-142,774.
	www.ftc.gov /os/2003/04/pfizeranalysis.htm (3871 words)

	Pfizer Inc., and Pharmacia Corporation
		Pfizer Inc., and Pharmacia Corporation will divest pharmaceutical products in nine separate product markets to different third parties to settle Federal Trade Commission charges that the merger of Pharmacia and Pfizer likely would have anticompetitive effects in those product markets and violate antitrust laws.
		Pharmacia, based in Peapack, New Jersey, is engaged in the research, development, manufacture, and sale of pharmaceutical products, animal health products, fine chemicals, and consumer health products.
		The loss of Pharmacia as an independent competitor in the OTC cough drop market is likely to lead to higher prices for consumers, the FTC alleges.
	www.ftc.gov /opa/2003/04/pfizer.htm (1936 words)

	RTE Business - Pfizer expands with Pharmacia buy
		Drug maker Pfizer has agreed to buy rival Pharmacia Corporation for $60 billion, the companies announced this morning in what would be the biggest corporate merger in more than a year.
		Pharmacia, which makes Nicorette, has three facilities in Ireland employing 200 people, while Pfizer employs 1,200 people here.
		Under terms of the deal, Pharmacia will proceed with previously announced plans to spin off its remaining 84% ownership of Monsanto to its current shareholders.
	www.rte.ie /business/2002/0715/pfizer.html (186 words)

	Minnesota Attorney General Sues Pharmacia (Site not responding. Last check: 2007-10-13)
		Pharmacia spokesman Paul Fitzhenry told the Pioneer Press that the company has not yet reviewed the suit and declined to comment on Hatch's allegations.
		The state is going after Pharmacia because it allegedly set a fraudulent price to begin with, then marketed the spread between that price and the actual price.
		Pharmacia's wide spread on drugs like Vincasar won business from doctors, thus boosting the firm's sales and its market share, Hatch contends.
	hr.blr.com /display.cfm/id/4235/site_nav/off (491 words)

	PFIZER/PHARMACIA [2003] ECComm 2 (27 February 2003)
		Second, the Commission notes that Pharmacia's product Adesipress is off patent, its market share is relatively small and has been declining over the years and that, at the same time, competitors such as Italfranco and Errekappa, have been able to steadily increase their market share.
		Pharmacia: Pharmacia is incorporated under the laws if the State of Delaware, USA with its registered office at 100 Route 206, North Peapack, New Jersey, 07977, USA.
		Pharmacia is developing apomorphine nasal spray for the treatment of human sexual dysfunction pursuant to an Agreement between Pharmacia and Nastech Pharmaceutical Company, Inc. ("Nastech") (the "Nastech Agreement").
	www.worldlii.org /eu/cases/ECComm/2003/2.html (16208 words)

	News Alert 7/18/02: Pfizer/Pharmacia
		Like other pharmaceutical companies, Pfizer and Pharmacia gave most of their political contributions in the form of big soft money contributions to the national parties.
		The Senate today is debating a measure that would sharply curb the ability of drug companies to extend their patents on particular drugs, a move that in the past has prevented the creation of more affordable, generic knock-offs.
		Even before its announced merger, Pfizer was among the most aggressive in the industry when it comes to fending off legislation that would seemingly make patent laws more lax, claiming that such legislation would curb the industry’s research and development into drugs that could cure rare diseases.
	www.opensecrets.org /alerts/v6/alertv6_58.asp (589 words)

	Pharmacia 4Q earnings drop - Feb. 5, 2002
		Excluding a series of charges, but including the agricultural business of Monsanto, which Pharmacia partially spun off last year, Pharmacia earned $197 million, or 15 cents a share, compared with $246 million, or 19 cents a share, a year earlier.
		Pharmacia said it expects to complete its spinoff of Monsanto in the fourth quarter of 2002.
		Pharmacia's quarterly sales rose to $3.68 billion from $3.33 billion a year earlier, led by $904 million in sales of Celebrex, compared with $772 million a year earlier.
	money.cnn.com /2002/02/05/companies/pharmacia/index.htm (317 words)

	Hospice Pharmacia (Site not responding. Last check: 2007-10-13)
		Hospice Pharmacia’s mission is to enhance the quality of life for hospice patients, nurses, and administrators by providing consistent high quality cost-effective pharmaceutical care.
		Hospice Pharmacia offers hospice partners a comprehensive “shared risk” per diem billing model to manage medication costs—because HP assumes financial responsibility for the management of palliative symptoms, optimized outcomes are assured and patients’ symptoms are controlled.
		Hospice Pharmacia is the only pharmacy company that enables its partners to have real-time profiling and monitoring of patient medications and conditions.
	www.hospicepharmacia.com /aboutus.asp (444 words)

	Crops, Shmops. Pharmacia Spins Off Monsanto - Forbes.com
		As expected, Pharmacia will spin off its 85% stake in Monsanto to shareholders, after floating 15% of the crop company in a fourth-quarter 2000 IPO.
		Pharmacia (nyse: PHA - news - people) never had any interest in crops.
		When Pharmacia and Upjohn bought the old Monsanto in April of 2000 for $23 billion, it was largely for the company's G.D. Searle drug division and its promising pipeline.
	www.forbesimg.com /2001/11/28/1128pha.html (772 words)

	DeepBridge
		Pharmacia Corporation (NYSE: PHA) is a leading global pharmaceutical company created through the merger of Pharmacia and Upjohn with Monsanto Company and its G.D. Searle unit.
		The 'new' Pharmacia needed to rebrand itself quickly using a completely new corporate portal focused more on the customer and less on specific pharmaceutical products.
		Since the site is fully dynamic and database driven, Pharmacia has the invaluable ability to self-publish important product prescribing information via the administrative site, quickly and easily.
	www.deepbridge.com /clients/pharmacia.htm (264 words)

Try your search on: Qwika (all wikis)